Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg

Fernández-Barrena, Maite G., Arechederra, María, Colyn, Leticia, Berasain, Carmen, Avila, Matias A.·2020·JHEP Reports
DOI 10.1016/j.jhepr.2020.100167

Cited by (126)

Items 101–126 of 126

  1. Epigenetic mechanisms and therapeutic targeting across diverse malignancies
    Akshara Harihar, Rithika Venkataramanan, Marina Alice Mathew, Anuraag Dasgupta, Koustav Sarkar · 2026 · Epigenomics
  2. HCV-Induced Hepatocarcinogenesis: Molecular Mechanisms, Persistent Cancer Risk, and Future Perspectives
    S. Jovanovic-Cupic, Milena Krajnović, Lidija Todorović, A. Božović, D. Galun · 2026 · Biomedicines
  3. Gene Expression Aberrations in Alcohol-Associated Hepatocellular Carcinoma
    Andreja Petrović, Paula Štancl, Paula Gršković, Suzana Hančić, Rosa Karlić, Slavko Gašparov, Petra Korać · 2024 · International Journal of Molecular Sciences
  4. Novel epitranscriptomic and epigenetic therapeutic strategies and targets for ferroptosis in liver fibrosis
    Minghui Li, Yang Yang, Qi-Qi Dong, Hui Tao, Chao Lu, Jingjing Yang · 2025 · European Journal of Pharmacology
  5. The emerging role of epigenetics (DNA methylation) in hepatitis C virus-induced hepatocellular carcinoma
    Ayma Aftab, Humera Naveed, Habiba Idrees, Liaqat Ali, Muhammad Idrees, Samia Afzal · 2025 · Gastrointestinal Tumors
  6. Papel de SLU7 en la regulación epigenética de la expresión génica: control de la estabilidad de DNMT1 y la metilación del DNA
    Miriam Recalde · 2022
  7. Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
    Bilbao, Idoia, Recalde, Miriam, Daian, Fabrice, Herranz, José Maria, Elizalde, María, Iñarrairaegui, Mercedes, Canale, Matteo, Fernández-Barrena, Maite G., Casadei-Gardini, Andrea, Sangro, Bruno et al. · 2024 · Journal of Physiology and Biochemistry
  8. Demystification of CLSPN multiple potentialities in hepatocellular carcinoma: insight into individualized diagnosis and precision therapeutics
    Yanlong Shi, Yizhu Wang, Kaiyi Niu, Wenning Zhang, Yewei Zhang · 2023 · Research Square
  9. UBE4B modulates BET inhibitor sensitivity via KLHL22-JAK2-PIM1 axis in hepatocellular carcinoma
    Li Wang, Xia‐Juan Huan, Shanshan Song, Xubin Bao, Chang-Qing Tian, Ze‐Hong Miao, Ying-Qing Wang · 2025 · Biochemical Pharmacology
  10. Temporal Dynamics of Somatic Mutations in Tumor and Plasma Samples From Hepatocellular Carcinoma Patients Pre‐ and Post‐Radioactive Particle Implantation: A Whole‐Exome Sequencing Study
    Hongxin Niu, Jian Wang, Huirong Xu, Hao Liang, Jianqi Li · 2025 · Biotechnology and Applied Biochemistry
  11. Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma
    Amaya López-Pascual, Jasmin Elurbide, Emiliana Valbuena-Goiricelaya, Maria Ujue Latasa, Elena Anaya, Elena Adán-Villaescusa, Borja Castelló-Uribe, Luz Andrea Martínez‐Pérez, Iker Uriarte, María Arechederra et al. · 2026 · Frontiers in Cell and Developmental Biology
  12. Additional file 4 of SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma
    Zhang, Yanping, Wanwen Lao, Kaming Yang, Kong, Xinyi, Li, Yuetong, Xin Yu, Wang, Xumeng, Yang Liu, Li, Zhenlin, Deng, Yilin et al. · 2024 · Figshare
  13. Additional file 3 of SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma
    Zhang, Yanping, Wanwen Lao, Kaming Yang, Kong, Xinyi, Li, Yuetong, Xin Yu, Wang, Xumeng, Liu, Yang, Li, Zhenlin, Deng, Yilin et al. · 2024 · Figshare
  14. Additional file 2 of SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma
    Zhang, Yanping, Wanwen Lao, Kaming Yang, Kong, Xinyi, Li, Yuetong, Xin Yu, Wang, Xumeng, Yang Liu, Li, Zhenlin, Deng, Yilin et al. · 2024 · Figshare
  15. Additional file 1 of SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma
    Zhang, Yanping, Wanwen Lao, Kaming Yang, Kong, Xinyi, Li, Yuetong, Xin Yu, Wang, Xumeng, Liu, Yang, Li, Zhenlin, Deng, Yilin et al. · 2023 · Figshare
  16. Future of Regenerative Hepatology
    Javier Martínez-García, Álvaro Blanes-Rodríguez, Sandra Melitón Barbancho, Marta Sáinz Viartola, Pedro M. Baptista · 2026 · Springer eBooks
  17. Epigenetics in angiogenesis, gastrointestinal cancer progression and its clinical significance
    A.N. Chandana, N. Bhagya · 2026 · Elsevier eBooks
  18. DNA methylation and histone modification in liver cancer
    Gayatri Gouda, Manoj Gupta, Ramakrishna Vadde · 2026 · Elsevier eBooks
  19. Epigenetic drug control of Clec4g/LSECtin expression reduces fibrosis burden in cirrhosis
    Enrique Ángel‐Gomis, Isabel Gómez‐Hurtado, Maite G. Fernández-Barrena, Oriol Juanola, Sebastián Martínez‐López, Paula Boix, Matías A. Ávila, Esther Caparrós, Rubén Francés · 2026 · Hepatology Communications
  20. Histone Methylation: A Pivotal Epigenetic Driver of the Malignant Transformation of MASLD-HCC
    Yan Zhang, Tong Chen, Zhanjie Chang, Xinlei Qi, Ruijuan Yan, Haitao Zhang, Xi Guan, Shuguang Yan, Jingtao Li, Junzhe Jiao · 2026 · Journal of Hepatocellular Carcinoma
  21. Hepatitis B virus–induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities
    Atahar Husein, Azfar Jamal, Mohammad Azhar Kamal, Yaser E. Alqurashi, Esam S. Al-Malki, Mohammed M. Naiyer, Syed Arif Hussain, Mohiuddin Khan Warsi · 2026 · Cancer Gene Therapy
  22. Integrated Bioinformatics and Multi-Omics Analysis of ZBTB40 Expression, Prognostic Relevance, and Regulatory Networks in Hepatocellular Carcinoma
    Tae-Young Kim, Jae-Hee Park, Yong Wook Jung, Jae‐Ho Lee, Jongwan Kim · 2026 · Medicina
  23. Artificial intelligence driven exposome and multi omics integration for biomarker discovery in liver cancer: a literature review
    Xuelian Wang, Gao Y, Ran Xu, Xin Lan, Qiushi Huang · 2026 · Frontiers in Immunology
  24. Molecular Signaling Pathways, Regulatory and Coactivator Networks, and Emerging Mechanisms in Hepatocellular Carcinoma
    Rohit Kumar Srivastava, Pratibha Singh, David Michael Lonard · 2026 · Biomedicines
  25. Crosstalk between PI3K/AKT signaling and epigenetic regulation in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities
    Zhibo Zhang, Jie Liu, Guofeng Lei, Xinjun Hu · 2026 · Frontiers in Cell and Developmental Biology
  26. DNMT3a Regulates the Proliferation and Apoptosis of Hepatocellular Carcinoma Cells Through RYBP Methylation
    Weijun Zhang, Rui Wang · 2026 · Molecular Carcinogenesis